145 related articles for article (PubMed ID: 31146084)
1. Altered microRNA 5692b and microRNA let-7d expression levels in children and adolescents with attention deficit hyperactivity disorder.
Aydin SU; Kabukcu Basay B; Cetin GO; Gungor Aydin A; Tepeli E
J Psychiatr Res; 2019 Aug; 115():158-164. PubMed ID: 31146084
[TBL] [Abstract][Full Text] [Related]
2. Changes in serum miRNA-let-7 level in children with attention deficit hyperactivity disorder treated by repetitive transcranial magnetic stimulation or atomoxetine: An exploratory trial.
Cao P; Wang L; Cheng Q; Sun X; Kang Q; Dai L; Zhou X; Song Z
Psychiatry Res; 2019 Apr; 274():189-194. PubMed ID: 30807970
[TBL] [Abstract][Full Text] [Related]
3. Gray matter volume and microRNA levels in patients with attention-deficit/hyperactivity disorder.
Wang LJ; Li SC; Kuo HC; Chou WJ; Lee MJ; Chou MC; Tseng HH; Hsu CF; Lee SY; Lin WC
Eur Arch Psychiatry Clin Neurosci; 2020 Dec; 270(8):1037-1045. PubMed ID: 31240443
[TBL] [Abstract][Full Text] [Related]
4. Circulating MicroRNA Let-7d in Attention-Deficit/Hyperactivity Disorder.
Wu LH; Peng M; Yu M; Zhao QL; Li C; Jin YT; Jiang Y; Chen ZY; Deng NH; Sun H; Wu XZ
Neuromolecular Med; 2015 Jun; 17(2):137-46. PubMed ID: 25724585
[TBL] [Abstract][Full Text] [Related]
5. Profiling of miRNAs in serum of children with attention-deficit hyperactivity disorder shows significant alterations.
Zadehbagheri F; Hosseini E; Bagheri-Hosseinabadi Z; Rekabdarkolaee HM; Sadeghi I
J Psychiatr Res; 2019 Feb; 109():185-192. PubMed ID: 30557705
[TBL] [Abstract][Full Text] [Related]
6. Chronotypical characteristics and related miR-142-3p levels of children with attention deficit and hyperactivity disorder.
Karadag M; Gokcen C; Nacarkahya G; Namiduru D; Dandil F; Calisgan B; Eroğlu S
Psychiatry Res; 2019 Mar; 273():235-239. PubMed ID: 30658207
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of several micro RNA (miRNA) levels in children and adolescents with attention deficit hyperactivity disorder.
Kandemir H; Erdal ME; Selek S; Ay Öİ; Karababa IF; Kandemir SB; Ay ME; Yılmaz ŞG; Bayazıt H; Taşdelen B
Neurosci Lett; 2014 Sep; 580():158-62. PubMed ID: 25123444
[TBL] [Abstract][Full Text] [Related]
8. miRNA profiling in the hippocampus of attention-deficit/hyperactivity disorder rats.
Tian T; Zhang Y; Wu T; Yang L; Chen C; Li N; Li Y; Xu S; Fu Z; Cui X; Ji C; Chi X; Tong M; Chen R; Hong Q; Hu Y
J Cell Biochem; 2019 Mar; 120(3):3621-3629. PubMed ID: 30270454
[TBL] [Abstract][Full Text] [Related]
9. [Association of microRNA expression before and after drug therapy with clinical symptoms in children with attention deficit hyperactivity disorder].
Zhang F; Zhu P; Wu LH
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Feb; 22(2):152-157. PubMed ID: 32051083
[TBL] [Abstract][Full Text] [Related]
10. Expression Patterns of miRNAs in Egyptian Children with ADHD: Clinical Study with Correlation Analysis.
Zeidan HM; Nashaat NH; Hemimi M; Hashish AF; Elsaeid A; Abd El-Ghaffar N; Helal SI; Meguid NA
J Mol Neurosci; 2024 Apr; 74(2):46. PubMed ID: 38652370
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic signature for attention-deficit/hyperactivity disorder: identification of miR-26b-5p, miR-185-5p, and miR-191-5p as potential biomarkers in peripheral blood mononuclear cells.
Sánchez-Mora C; Soler Artigas M; Garcia-Martínez I; Pagerols M; Rovira P; Richarte V; Corrales M; Fadeuilhe C; Padilla N; de la Cruz X; Franke B; Arias-Vásquez A; Casas M; Ramos-Quiroga JA; Ribasés M
Neuropsychopharmacology; 2019 Apr; 44(5):890-897. PubMed ID: 30568281
[TBL] [Abstract][Full Text] [Related]
12. Preliminary evidence for association of genetic variants in pri-miR-34b/c and abnormal miR-34c expression with attention deficit and hyperactivity disorder.
Garcia-Martínez I; Sánchez-Mora C; Pagerols M; Richarte V; Corrales M; Fadeuilhe C; Cormand B; Casas M; Ramos-Quiroga JA; Ribasés M
Transl Psychiatry; 2016 Aug; 6(8):e879. PubMed ID: 27576168
[TBL] [Abstract][Full Text] [Related]
13. Integrated Analysis of microRNA and mRNA Expression Profiles: An Attempt to Disentangle the Complex Interaction Network in Attention Deficit Hyperactivity Disorder.
Nuzziello N; Craig F; Simone M; Consiglio A; Licciulli F; Margari L; Grillo G; Liuni S; Liguori M
Brain Sci; 2019 Oct; 9(10):. PubMed ID: 31652596
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA profile as potential molecular signature for attention deficit hyperactivity disorder in children.
Zhu P; Pan J; Cai QQ; Zhang F; Peng M; Fan XL; Ji H; Dong YW; Wu XZ; Wu LH
Biomarkers; 2022 May; 27(3):230-239. PubMed ID: 34989306
[TBL] [Abstract][Full Text] [Related]
15. [Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?].
Villemonteix T; Purper-Ouakil D; Romo L
Encephale; 2015 Apr; 41(2):108-14. PubMed ID: 24703785
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of serum neopterin in attention deficit/hyperactivity disorder (ADHD).
Ceylan MF; Uneri OS; Guney E; Ergin M; Alisik M; Goker Z; Senses Dinc G; Karaca Kara F; Erel O
J Neuroimmunol; 2014 Aug; 273(1-2):111-4. PubMed ID: 24969118
[TBL] [Abstract][Full Text] [Related]
17. Decreased serum orexin A levels in drug-naive children with attention deficit and hyperactivity disorder.
Baykal S; Albayrak Y; Durankuş F; Güzel S; Abbak Ö; Potas N; Beyazyüz M; Karabekiroğlu K; Donma MM
Neurol Sci; 2019 Mar; 40(3):593-602. PubMed ID: 30617449
[TBL] [Abstract][Full Text] [Related]
18. Peripheral whole blood microRNA alterations in major depression and bipolar disorder.
Maffioletti E; Cattaneo A; Rosso G; Maina G; Maj C; Gennarelli M; Tardito D; Bocchio-Chiavetto L
J Affect Disord; 2016 Aug; 200():250-8. PubMed ID: 27152760
[TBL] [Abstract][Full Text] [Related]
19. Emerging role of miRNA in attention deficit hyperactivity disorder: a systematic review.
Srivastav S; Walitza S; Grünblatt E
Atten Defic Hyperact Disord; 2018 Mar; 10(1):49-63. PubMed ID: 28493018
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D status in children with attention-deficit-hyperactivity disorder.
Goksugur SB; Tufan AE; Semiz M; Gunes C; Bekdas M; Tosun M; Demircioglu F
Pediatr Int; 2014 Aug; 56(4):515-9. PubMed ID: 24417979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
